Epidemiology and Outcomes of Hospitalized Patients with Hematological Malignancy and Acute Respiratory Failure

ARF affects more than one in 10 hospitalized patients with hematologic malignancies. Although improved compared to historical data, it remains linked to increased mortality and healthcare utilization, particularly among those requiring IMV. These findings highlight the need for early risk stratification and targeted interventions to improve outcomes in this high-risk population.